ajocysteine

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: ajocysteine
• 英文别名: 2-amino-3-[[(E)-3-prop-2-enylsulfinylprop-1-enyl]disulfanyl]propanoic acid
• 化学式: C₉H₁₅NO₃S₃
• 分子量: 281.421
• InChiKey: URBPKPSYQPHFAT-ONEGZZNKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.5
• 重原子数：
  16
• 可旋转键数：
  9
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  150
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  DL-半胱氨酸 、 (E)-ajoene 生成 ajocysteine
  参考文献：
  名称：

  [EN] INTEGRIN MODULATORS AND METHODS FOR THEIR USE
  [FR] MODULATEURS D'INTEGRINE ET METHODES D'UTILISATION DE CES MODULATEURS

  摘要：

  描述了1,5-二硫杂辛二烯-5-氧化-1-基(DODOyl)化合物及其衍生物，统称为DODOyl衍生化合物(DDCs)，以及手性对映体和其衍生物，它们是调节整合素介导功能和/或过程的整合素调节剂。进一步描述了含有整合素调节剂和手性对映体的药物组合物，以及使用整合素调节剂和手性对映体的方法。

  公开号：

  WO2005087717A1

文献信息

• Integrin Modulators and Methods for their Use
  申请人：Davidson John B.

  公开号：US20080234388A1

  公开（公告）日：2008-09-25

  1,5-Dithiaocta-2,7-diene-5-oxide-1-yl (DODOyl) compounds and derivatives thereof, referred to collectively as DODOyl-derived compounds (DDCs), and chiral enantiomers and derivatives thereof, are described, which are integrin modulators that modulate integrin-mediated functions and/or processes. Pharmaceutical compositions containing integrin modulators and chiral enantiomers thereof, and methods for using integrin modulators and chiral enantiomers thereof are further described.
• Integrin modulators and methods for their use
  申请人：Davidson John B.

  公开号：US20100099917A1

  公开（公告）日：2010-04-22

  1,5-Dithiaocta-2,7-diene-5-oxide-1-yl(DODOyl) compounds and derivatives thereof, referred to collectively as DODOyl-derived compounds (DDCs), and chiral enantiomers and derivatives thereof, are described, which are integrin modulators that modulate integrin-mediated functions and/or processes. Pharmaceutical compositions containing integrin modulators and chiral enantiomers thereof, and methods for using integrin modulators and chiral enantiomers thereof are further described.
• Integrin Modulators and Methods for Their Use
  申请人：Davidson John B.

  公开号：US20120149940A1

  公开（公告）日：2012-06-14

  1,5-Dithiaocta-2,7-diene-5-oxide-1-yl (DODOyl) compounds and derivatives thereof, referred to collectively as DODOyl-derived compounds (DDCs), and chiral enantiomers and derivatives thereof, are described, which are integrin modulators that modulate integrin-mediated functions and/or processes. Pharmaceutical compositions containing integrin modulators and chiral enantiomers thereof, and methods for using integrin modulators and chiral enantiomers thereof are further described.